RC
BMY icon

Rexford Capital’s Bristol-Myers Squibb BMY Stock Holding History

Rexford Capital’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$376K Buy
6,206
+205
+3% +$12K 0.27% 110
2025
Q4 		$324K Sell
6,001
-600
-9% -$28.9K 0.25% 116
2025
Q3 		$298K Buy
6,601
+170
+3% +$7.94K 0.23% 128
2025
Q2 		$298K Buy
+6,431
New +$316K 0.25% 124

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Rexford Capital's BMY Position: Q1 2026 in Review

Rexford Capital increased its Bristol-Myers Squibb (BMY) stake by 3.4% in Q1 2026, buying an estimated $12K and bringing the position to 6,206 shares worth $376K. The position accounts for 0.27% of the portfolio, ranked #110.

Rexford Capital first reported a position in BMY in Q2 2025 and has held it in 4 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Rexford Capital held 6,206 shares of Bristol-Myers Squibb worth $376K as of Q1 2026.
  • Rexford Capital bought 205 Bristol-Myers Squibb shares in Q1 2026, an estimated $12K.
  • Bristol-Myers Squibb made up 0.27% of Rexford Capital's portfolio in Q1 2026, its #110 holding.
  • Rexford Capital first reported a position in Bristol-Myers Squibb in Q2 2025 and has held it in 4 quarters since.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Rexford Capital's 13F filing for Q1 2026, filed 24 Apr 2026.